Task: Answer the MCQ question.
Query: Which drug exhibits a -69.014% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a. Cc1cc(N2CCOCC2)n2cc(-c3ccc(F)cc3)nc2n1
b. COc1ccc(S(=O)(=O)N2CC(C(=O)O)Oc3ccccc32)cc1
c. CC(C(=O)NCCc1ccccc1)N1c2cccc3cccc(c23)S1(=O)=O
d. O=C(COc1ccc(Br)cc1CNC1CCCCC1)NCCc1ccccc1
Answer: a. Cc1cc(N2CCOCC2)n2cc(-c3ccc(F)cc3)nc2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(N2CCOCC2)n2cc(-c3ccc(F)cc3)nc2n1
Cc1cc(N2CCOCC2)n2cc(-c3ccc(F)cc3)nc2n1
4-[2-(4-fluorophenyl)-7-methylimidazo[1,2-a]pyrimidin-5-yl]morpholine